Literature DB >> 12393582

Transgenic targeting with regulatory elements of the human CD34 gene.

Hanna S Radomska1, David A Gonzalez, Yutaka Okuno, Hiromi Iwasaki, Andras Nagy, Koichi Akashi, Daniel G Tenen, Claudia S Huettner.   

Abstract

The human CD34 gene is expressed on early progenitor and stem cells in the bone marrow. Here we report the isolation of the human CD34 locus from a human P1 artificial chromosome (PAC) library and the characterization and evaluation of this genomic fragment for expression of reporter genes in stable cell lines and transgenic mice. We show that a 160-kb fragment spanning 110 kb of the 5' flanking region and 26 kb of the 3' flanking region of the CD34 gene directs expression of the human CD34 gene in the bone marrow of transgenic mice. The expression of human CD34 transgenic RNA in tissues was found to be similar to that of the endogenous murine CD34 gene. Colony-forming cell assays showed that bone marrow cells staining positive for human CD34 consist of early progenitor cells in which expression of CD34 decreased with cell maturation. In order to test the construct for its ability to express heterologous genes in vivo, we used homologous recombination in bacteria to insert the tetracycline-responsive transactivator protein tTA. Analysis of transgenic human CD34-tTA mice by cross breeding with a strain carrying Cre recombinase under control of a tetracycline-responsive element demonstrated induction of Cre expression in mice in a pattern consistent with the expression of the human CD34 transgene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393582     DOI: 10.1182/blood-2002-02-0355

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Artificial chromosome-based transgenes in the study of genome function.

Authors:  Jason D Heaney; Sarah K Bronson
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

Review 2.  Organ-on-a-chip: development and clinical prospects toward toxicity assessment with an emphasis on bone marrow.

Authors:  Jeehye Kim; Hanna Lee; Šeila Selimović; Robert Gauvin; Hojae Bae
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.606

3.  A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation.

Authors:  Hanna S Radomska; Finith Jernigan; Sohei Nakayama; Susan E Jorge; Lijun Sun; Daniel G Tenen; Susumu S Kobayashi
Journal:  J Biomol Screen       Date:  2015-06-24

4.  Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.

Authors:  John A Pulikkan; Viola Dengler; Philomina S Peramangalam; Abdul A Peer Zada; Carsten Müller-Tidow; Stefan K Bohlander; Daniel G Tenen; Gerhard Behre
Journal:  Blood       Date:  2009-12-22       Impact factor: 22.113

5.  RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element.

Authors:  Elena Levantini; Sanghoon Lee; Hanna S Radomska; Christopher J Hetherington; Meritxell Alberich-Jorda; Giovanni Amabile; Pu Zhang; David A Gonzalez; Junyan Zhang; Daniela S Basseres; Nicola K Wilson; Steffen Koschmieder; Gang Huang; Dong-Er Zhang; Alexander K Ebralidze; Constanze Bonifer; Yutaka Okuno; Bertie Gottgens; Daniel G Tenen
Journal:  EMBO J       Date:  2011-08-26       Impact factor: 11.598

6.  Essential role of brain-derived neurotrophic factor in adult hippocampal function.

Authors:  Lisa M Monteggia; Michel Barrot; Craig M Powell; Olivier Berton; Victor Galanis; Terry Gemelli; Sven Meuth; Andreas Nagy; Robert W Greene; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.

Authors:  J G Harb; P Neviani; B J Chyla; J J Ellis; G J Ferenchak; J J Oaks; C J Walker; P Hokland; D C Roy; M A Caligiuri; G Marcucci; C S Huettner; D Perrotti
Journal:  Leukemia       Date:  2013-05-14       Impact factor: 11.528

8.  Induction of a hemogenic program in mouse fibroblasts.

Authors:  Carlos-Filipe Pereira; Betty Chang; Jiajing Qiu; Xiaohong Niu; Dmitri Papatsenko; Caroline E Hendry; Neil R Clark; Aya Nomura-Kitabayashi; Jason C Kovacic; Avi Ma'ayan; Christoph Schaniel; Ihor R Lemischka; Kateri Moore
Journal:  Cell Stem Cell       Date:  2013-06-13       Impact factor: 24.633

9.  Loss of Bcl-x in Ph+ B-ALL increases cellular proliferation and does not inhibit leukemogenesis.

Authors:  Jason G Harb; Brenda I Chyla; Claudia S Huettner
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

10.  Manipulating gene activity in Wnt1-expressing precursors of neural epithelial and neural crest cells.

Authors:  Wei Hsu; Anthony J Mirando; Hsiao-Man Ivy Yu
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.